TRAF7 Antikörper (AA 260-400)
Kurzübersicht für TRAF7 Antikörper (AA 260-400) (ABIN7270838)
Target
Alle TRAF7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 260-400
-
Verwendungszweck
- TRAF7 Rabbit pAb
-
Sequenz
- PHSKYGCTFI GNQDTYETHL ETCRFEGLKE FLQQTDDRFH EMHVALAQKD QEIAFLRSML GKLSEKIDQL EKSLELKFDV LDENQSKLSE DLMEFRRDAS MLNDELSHIN ARLNMGILGS YDPQQIFKCK GTFVGHQGPV W
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 260-400 of human TRAF7 (NP_115647.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- TRAF7 (TNF Receptor-Associated Factor 7 (TRAF7))
-
Andere Bezeichnung
- TRAF7
-
Hintergrund
- Tumor necrosis factor (TNF, see MIM 191160) receptor-associated factors, such as TRAF7, are signal transducers for members of the TNF receptor superfamily (see MIM 191190). TRAFs are composed of an N-terminal cysteine/histidine-rich region containing zinc RING and/or zinc finger motifs, a coiled-coil (leucine zipper) motif, and a homologous region that defines the TRAF family, the TRAF domain, which is involved in self-association and receptor binding.,TRAF7,RFWD1,RNF119,Cell Biology & Developmental Biology,Apoptosis,Ubiquitin,Immunology & Inflammation,Cytokines,TNF,Cell Intrinsic Innate Immunity Signaling Pathway,TRAF7
-
Molekulargewicht
- 66kDa/74kDa
-
Gen-ID
- 84231
-
UniProt
- Q6Q0C0
Target
-